VolitionRX Ltd (VNRX)

VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France

VolitionRx Participates in Launch of DETECSEPS Program in France

VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027

Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference

VolitionRX (NYSEAMERICAN:VNRX) Share Price Crosses Below Fifty Day Moving Average – Here’s Why

Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations

VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets

Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis

VolitionRx Limited (VNRX) Q2 2026 Earnings Call Transcript

VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update

Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients

VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update

Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology

Volition Advances Nu.Q® NETs Platform Towards Commercialization